SCOPUS 정보 검색 플랫폼 - 논문 보기

메뉴 건너뛰기

Clinical Toxicology

Volumn 32, Issue 5, 1994, Pages 583-587

Characterization of 4-aminopyridine in overdose

(2) Stork, Christine M a,b Hoffman, Robert S a,b

a BELLEVUE HOSPITAL CENTER (United States)

b NEW YORK UNIVERSITY MEDICAL CENTER (United States)

Author keywords

Aminopyridine; Human; Poisoning

Indexed keywords

4 AMINOPYRIDINE; ACTIVATED CARBON; BENZODIAZEPINE; DIAZEPAM; LORAZEPAM; PHENOBARBITAL; PHENYTOIN;

ADULT; ARTICLE; CASE REPORT; DRUG OVERDOSE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MULTIPLE SCLEROSIS; SEIZURE;

4-AMINOPYRIDINE; ADULT; CASE REPORT; FEMALE; HUMAN; MIDDLE AGE; MULTIPLE SCLEROSIS; OVERDOSE; PHENYTOIN;

EID: 0028148351 PISSN: 15563650 EISSN: None Source Type: Journal
DOI: 10.3109/15563659409011063 Document Type: Article

Times cited : (53)

References (24)

1
- 84958855478
- Office of Orphan Products Development. July
- (1991) Orphan Drug Designations to June 30, 1991.

2
- 0025277902
- The myasthenic syndrome: anaesthesia in a patient treated with 3,4 diaminopyridine
- (1990) Br J Anaesth , vol.64 , pp. 363-366
- Telford, R.J.¹ Hollway, T.E.²

3
- 0025253455
- Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis
- (1990) Ann Neurol , vol.27 , pp. 186-192
- Davis, F.A.¹ Stefoski, D.² Rush, J.³

4
- 0025318536
- Preliminary trial of 3,4 diaminopyridine in patients with multiple sclerosis
- (1990) Ann Neurol , vol.27 , pp. 421-427
- Bever, C.T.¹ Leslie, J.² Camenga, D.L.³

5
- 0023134727
- 4-aminopyridine improves clinical signs in multiple sclerosis
- (1987) Ann Neurol , vol.21 , pp. 71-77
- Stefoski, D.¹ Davis, F.A.² Faut, M.³ Schauf, C.L.⁴

6
- 0026719595
- The effect of 4-aminopyridine on clinical signs in multiple sclerosis: a randomized, placebo-controlled, double-blind, cross-over study
- (1992) Ann Neuro , vol.32 , pp. 123-130
- Van Diemen, H.A.¹ Polman, C.H.² Van Dongen, T.M.³

7
- 0025989270
- 4-aminopyridine in multiple sclerosis: prolonged administration
- (1991) Neurology , vol.41 , pp. 1344-1348
- Stefoski, D.¹ Davis, F.A.² Fitzsimmons, W.E.³

8
- 0026749898
- Increased visual impairment after exercise (Uhthoff's phenomenon) in multiple sclerosis: therapeutic possibilities
- (1992) Eur Neurol , vol.32 , pp. 231-234
- Van Diemen, H.A.¹ Van Dongen, M.M.² Dammers, J.W.³ Polman, C.H.⁴

9
- 0027314926
- 4-aminopyridine in patients with multiple sclerosis: dosage and serum level related to efficacy and safety
- (1993) Clin Neuropharmacol , vol.16 , pp. 195-204
- Van Diemen, H.A.¹ Polman, C.H.² Koetsier, J.C.³

10
- 0024226640
- Effects of 4-aminopyridine in experimental CNS demyelination
- (1988) Neurology , vol.38 , pp. 1884-1887
- Kaji, R.¹ Sumner, A.J.²

11
- 0019476136
- Treatment with oral 4-aminopyridine in disorders of neuromuscular transmission
- (1981) Neurology , vol.31 , pp. 265-271
- Murray, N.M.¹ Newsom Davis, J.²

12
- 0026081862
- Potassium channel blockers: Could they work in alzheimer's disease?
- (1991) Alzheimer's Dis Assoc Disord , vol.5 , pp. 25-30
- Wiseman, E.J.¹ Jarvik, L.F.²

13
- 0026705873
- Human type A botulism and treatment with 3,4 diaminopyridine
- (1992) Electromyogr Clin Neurophysiol , vol.32 , pp. 338-379
- Davis, L.E.¹ Johnson, J.K.² Bicknell, J.M.³

14
- 0025730112
- The effects of 4-aminopyridine on neurological deficits in chronic cases of traumatic spinal cord injury in dogs: a phase 1 clinical trial
- (1991) J Neurotrauma , vol.8 , pp. 103-119
- Blight, A.R.¹ Toombs, J.P.² Bauer, M.S.³ Widmer, W.R.⁴

15
- 0026322540
- 3,4-Diaminopyridine in the treatment of congenital (hereditary) myasthenia
- (1991) J Neurol Neurosurg Psychiatry , vol.54 , pp. 1069-1072
- Palace, J.¹ Wiles, C.M.² Newsom-Davis, J.³

16
- 0024367939
- 3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome
- (1989) N Engl J Med , vol.321 , pp. 1567-1571
- McEvoy, K.M.¹ Windebank, A.J.² Daube, J.R.³ Low, P.A.⁴

17
- 0023836044
- 4-Aminopyridine in the treatment of Alzheimer's disease
- (1988) Biol Psychiatry , vol.23 , pp. 485-490
- Davidson, M.¹ Zemishlany, Z.² Mohs, R.C.³

18
- 0024418456
- Effect of 4-aminopyridine on axonal conduction-block in chronic spinal cord injury
- (1989) Brain Res Bull , vol.22 , pp. 47-52
- Blight, A.R.¹

19
- 84958907336
- A reversed-phase ion-pair liquid chromatography method for the determination of 4-aminopyridine in Sprague-Dawley rats
- (1993) J Phisiochemical Biomedical Analysis , vol.6 , pp. 98-100
- Fossler, M.J.¹ Leslie, J.² Burke, M.³

20
- 0020321345
- The aminopyridines
- (1982) Gen Pharmacol , vol.13 , pp. 259-285
- Glover, W.E.¹

21
- 0019402518
- Pharmacokinetics of 4-aminopyridine in human volunteers. A preliminary study using a new GLC method for its estimation
- (1981) Br J Anaesth , vol.53 , pp. 567-570
- Evenhuis, J.¹ Agoston, S.² Salt, P.J.³

22
- 0018621819
- Human botulism caused by Clostridium botulinum type E: the Birmingham outbreak
- (1979) Q J Med , vol.48 , pp. 473-491
- Ball, A.P.¹ Hopkinson, R.B.² Farrell, I.D.³

23
- 0024094555
- Relative efficacy of phenytoin and phenobarbital for the prevention of theophylline induced seizures in mice
- (1988) Ann Emerg Med , vol.17 , pp. 1024-1028
- Blake, K.V.¹ Massey, K.L.² Hendeles, L.³

24
- 0026608653
- Effects of anticonvulsant drugs on 4-aminopyridine-induced seizures in mice
- (1992) Epilepsy Res , vol.11 , pp. 9-16
- Yamaguchi, S.¹ Rogawski, M.A.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.